General Information
Version
7.1
Revision date
2025-02-17
Product name
Sitagliptin Phosphate
CAS No.
654671-77-9
REACH No
A
Emergency telephone
+81 (3)4531-1145, +81 (0)3 4520 9637
Icons in SDS
Company Information
company name
Merck Ltd.
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H319, H373
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Eye irritation, (Category 2) H319: Causes serious eye irritation. Specific target organ toxicity - H373: May cause damage to organs repeated exposure, (Category 2), through prolonged or repeated exposure. Liver
Signal word
Warning Warning
Hazard statements
H319 Causes serious eye irritation. H373 May cause damage to organs (Liver) through prolonged or repeated exposure. none
Precautionary statements
P260 Do not breathe dust/ fume/ gas/ mist/ vapors/ spray. P264 Wash skin thoroughly after handling. P280 Wear eye protection/ face protection. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P314 Get medical advice/ attention if you feel unwell. P337 + P313 If eye irritation persists: Get medical advice/ attention. none
Supplemental label elements
none Reduced Labeling (<= 125 ml) none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.